483
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA 483, Mar 22, 2024
Record Details
An FDA inspection of Octapharma Plasma, Inc. in Dallas, TX, a source plasma center, revealed a significant quality control issue related to equipment calibration. The firm failed to ensure that weights used for plasma collection were calibrated against the proper weight standard, leading to an inability to determine equipment tolerance for critical devices. This lapse indicates a failure to comply with official requirements for equipment performance.
View Company Profile
ID · 20372d7d-8e3e-4efc-8f53-90b3f7d2fe76
Other documents for Octapharma Plasma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.